vimarsana.com

Latest Breaking News On - Centre for neonatal - Page 1 : vimarsana.com

Nirsevimab Protects Infants Against RSV-Linked Hospitalization

Nirsevimab is efficacious for preventing hospitalization for RSV-associated lower respiratory tract infection among infants.

Nirsevimab Protects Infants Against RSV-Linked Hospitalization

THURSDAY, Dec. 28, 2023 (HealthDay News) Nirsevimab is efficacious for preventing hospitalization for respiratory syncytial virus (RSV)-associated lower respiratory tract infection among infants, according to a study published in the Dec. 28 issue of the New England Journal of Medicine. Simon B. Drysdale, Ph.D., from the Centre for Neonatal and Paediatric Infections at the

Nirsevimab protects infants against RSV-linked hospitalization

Nirsevimab protects infants against RSV-linked hospitalization
medicalxpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medicalxpress.com Daily Mail and Mail on Sunday newspapers.

Antibiotic-resistant sepsis still claims newborn lives in Africa: Europe and Africa in scientific collaboration to save lives and improve treatment

Antibiotic-resistant sepsis still claims newborn lives in Africa: Europe and Africa in scientific collaboration to save lives and improve treatment
iol.co.za - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from iol.co.za Daily Mail and Mail on Sunday newspapers.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.